Phoenix Financial’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$315K Buy
1,457
+86
+6% +$16.5K ﹤0.01% 422
2026
Q1
$251K Sell
1,371
-1,762
-56% -$325K ﹤0.01% 422
2025
Q4
$551K Buy
+3,133
New +$512K 0.01% 286
2025
Q1
– Sell
-3,608
Closed -$552K – 376
2024
Q4
$552K Buy
+3,608
New +$609K 0.01% 254
2024
Q1
– Sell
-760
Closed -$207K – 432
2023
Q4
$207K Buy
+760
New +$187K ﹤0.01% 298
2023
Q3
– Sell
-2,194
Closed -$618K – 325
2023
Q2
$618K Buy
+2,194
New +$653K 0.01% 238
2022
Q1
– Sell
-1,332
Closed -$319K – 410
2021
Q4
$319K Sell
1,332
-202
-13% -$51.9K 0.01% 323
2021
Q3
$437K Buy
+1,534
New +$503K 0.01% 335
2021
Q2
– Sell
-1,849
Closed -$510K – 314
2021
Q1
$510K Buy
1,849
+519
+39% +$140K 0.01% 314
2020
Q4
$323K Sell
1,330
-7,416
-85% -$1.91M 0.01% 281
2020
Q3
$2.33M Buy
8,746
+1,795
+26% +$501K 0.1% 138
2020
Q2
$1.72M Sell
6,951
-5
-0.1% -$1.5K 0.07% 177
2020
Q1
$2.13M Buy
+6,956
New +$2.11M 0.11% 146

Other funds holding BIIB

Phoenix Financial's BIIB Position: Q2 2026 in Review

Phoenix Financial increased its Biogen (BIIB) stake by 6.3% in Q2 2026, buying an estimated $16.5K and bringing the position to 1,457 shares worth $315K. The position accounts for ﹤0.01% of the portfolio, ranked #422.

Phoenix Financial first reported a position in BIIB in Q1 2020 and has held it in 13 quarters since. The position peaked at $2.33M in Q3 2020. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Phoenix Financial held 1,457 shares of Biogen worth $315K as of Q2 2026.
  • Phoenix Financial bought 86 Biogen shares in Q2 2026, an estimated $16.5K.
  • Biogen made up ﹤0.01% of Phoenix Financial's portfolio in Q2 2026, its #422 holding.
  • Phoenix Financial first reported a position in Biogen in Q1 2020 and has held it in 13 quarters since.
  • Phoenix Financial's Biogen position peaked at $2.33M in Q3 2020.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Phoenix Financial's 13F filing for Q2 2026, filed 11 Aug 2026.